OneAI™ captures biospectral information from biologics to create objective, repeatable quality signatures that can be compared and tracked across samples, batches, doses, processes, and time—helping predict quality changes and guide manufacturing.
OneAI™ adds a repeatable, multidimensional analytical layer for comparing reference and biosimilar products across samples, batches, and dose levels—helping measure similarity, consistency, and meaningful change.
For Hard-To-Protect-Biologics (HTPBs) that are difficult to characterize precisely, repeatable biospectral signatures can provide an additional means of defining, differentiating, and documenting a product.
Unlocking quantum sensing, imaging, and superintelligence to develop new capabilities in drug-quality analysis... Explore QUANTUM